Martin H. Bolli - Concepedia

Author

Martin H. Bolli

Also Known As

Bolli, M.H., M Bolli, M. BOLLI, M. Bolli, M. H. BOLLI, Magali Vercauteren, Martin Bolli, Martin H Bolli, Martin H. Bolli

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

Actelion (Switzerland)University of Bern Scripps Research Institute École Polytechnique Fédérale de Lausanne Idorsia (Switzerland)

About

Martin H. Bolli is an author at Actelion (Switzerland) specializing in natural sciences, molecular biology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Natural Sciences	16	16	1.2K
2	Medicine	12	13	676
3	Biochemistry	12	13	1K
4	Engineering	7	7	301
5	Biology	1	1	62

Martin H. Bolli

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Pharmacology of Macitentan, an Orally Active Tissue-Targeting Dual Endothelin Receptor Antagonist Marc Iglarz, Christoph A. Binkert, Keith Morrison, Journal of Pharmacology and Experimental Therapeutics	2008	320
Pyranosyl-RNA: chiroselective self-assembly of base sequences by ligative oligomerization of tetra nucleotide-2′,3′-cyclophosphates (with a commentary concerning the origin of biomolecular homochirality) Martin H. Bolli, Ronald Micura, Albert Eschenmoser Chemistry & Biology Chiroselective Self-assemblyRna ProcessingNucleic Acid ChemistryBiochemistryBiomolecular Homochirality	1997	287
2-Imino-thiazolidin-4-one Derivatives as Potent, Orally Active S1P<sub>1</sub>Receptor Agonists Martin H. Bolli, Stefan Abele, Christoph A. Binkert, Journal of Medicinal Chemistry Molecular Pharmacology2-Imino-thiazolidin-4-one DerivativesG Protein-coupled ReceptorMedicineImmunology	2010	173
The Discovery of <i>N</i>-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-<i>N</i>′-propylsulfamide (Macitentan), an Orally Active, Potent Dual Endothelin Receptor Antagonist Martin H. Bolli, Christoph Boss, Christoph A. Binkert, Journal of Medicinal Chemistry HypertensionHigh Oral EfficacyCompound 17Orally ActivePharmacotherapy	2012	146
Nucleic‐Acid Analogues with Constraint Conformational Flexibility in the Sugar‐Phosphate Backbone (‘Bicyclo‐DNA’). Part 1. Preparation of (3<i>S</i>,5′<i>R</i>)‐2′‐Deoxy‐3′,5′‐ethano‐αβ‐<scp>D</scp>‐ribonucleosides (‘Bicyclonucleosides’) Markus Tarköy, Martin H. Bolli, W. Bernd Schweizer, Helvetica Chimica Acta Nucleic Acid ChemistryBioorganic ChemistryDnaBiochemistryPurine Nucleosides	1993	128
Pyranosyl‐RNA (‘p‐RNA’): Base‐pairing selectivity and potential to replicate. Preliminary communication Stefan Pitsch, Ramanarayanan Krishnamurthy, Martin H. Bolli, Helvetica Chimica Acta GeneticsMolecular BiologyMolecular GeneticsExceptional Pairing SelectivityNucleic Acid Chemistry	1995	123
Nucleic‐Acid Analogues with Restricted Conformational Flexibility in the Sugar‐Phosphate Backbone (‘bicyclo‐DNA’). Part 3. Synthesis, pairing properties, and calorimetric determination of duplex and triplex stability of decanucleotides from [(3′<i>S</i>,5′<i>R</i>)‐2′‐deoxy‐3′,5′‐ ethano‐β ‐<scp>D</scp>‐ribofuranosyl]adenine and ‐thymine Markus Tarköy, Martin H. Bolli, Christian J. Leumann Helvetica Chimica Acta Containing DuplexesNucleic Acid ChemistryBiochemistryNatural SciencesNucleic Acid Biochemistry	1994	116
The Selective Sphingosine 1-Phosphate Receptor 1 Agonist Ponesimod Protects against Lymphocyte-Mediated Tissue Inflammation Luca Piali, Sylvie Froidevaux, Patrick Hess, Journal of Pharmacology and Experimental Therapeutics	2011	105
Sphingosine 1-Phosphate (S1P) Receptor Agonists Mediate Pro-fibrotic Responses in Normal Human Lung Fibroblasts via S1P2 and S1P3 Receptors and Smad-independent Signaling Katrin Sobel, Katalin Menyhart, Nina Killer, Journal of Biological Chemistry	2013	96
Novel Benzo[1,4]diazepin-2-one Derivatives as Endothelin Receptor Antagonists Martin H. Bolli, Judith Marfurt, Corinna Grisostomi, Journal of Medicinal Chemistry	2004	76

Page 1